Endovascular Techniques in the Treatment of Acute Limb Ischemia: Thrombolytic Agents, Trials, and Percutaneous Mechanical Thrombectomy Techniques

Seminars in Vascular Surgery

Volumn 16, Issue 4, 2003, Pages 270-279

  Ouriel, Kenneth ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; PLASMINOGEN ACTIVATOR; PROLYSE; PROUROKINASE; RETEPLASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ALLERGIC REACTION; ARTERY BLOOD FLOW; BRONCHOSPASM; CLINICAL TRIAL; ENDOVASCULAR SURGERY; FEVER; HUMAN; LIMB ISCHEMIA; MORBIDITY; MORTALITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SURGICAL TECHNIQUE; THROMBECTOMY; URTICARIA;

EID: 0346099310     PISSN: 08957967     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2003.08.004     Document Type: Article

References (45)

1. Blaisdell FW, Steele M, Allen RE: Management of acute lower extremity arterial ischemia due to embolism and thrombosis. Surgery 84:822-834, 1978
2. Jivegård L, Holm J, Scherstén T: Acute limb ischemia due to arterial embolism or thrombosis: influence of limb ischemia versus pre-existing cardiac disease on postoperative mortality rate. J Cardiovasc Surg 29:32-36, 1998
3. Holm J, Scherstén T: Anticoagulant treatment during and after embolectomy. Acta Chir Scand 138:683-687, 1972
4. Caruana JA, Gutierrez IZ, Andersen MN, et al: Factors that affect the outcome of peripheral arterial embolization. Arch Surg 116:423-425, 1981
5. Ouriel K, Shortell CK, DeWeese JA, et al: A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 19:1021-1030, 1994
6. Ouriel K, Veith FJ, Sasahara AA: A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. N Engl J Med 338:1105-1111, 1998
7. Anonymous: Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity: The STILE trial. Ann Surg 220:251-266, 1994
8. Ouriel K, Kandarpa K, Schuerr DM, Hultquist M, Hodkinson G, Wallin B: Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial. J Vasc Interv Radiol 10:1083-1091, 1999
9. Dormandy J, Heeck L, Vig S: Acute limb ischemia. Semin Vasc Surg 12:148-153, 1999
10. Parsons RE, Marin ML, Veith FJ, et al: Fluoroscopically assisted thromboembolectomy: an improved method for treating acute arterial occlusions. Ann Vasc Surg 10:201-210, 1996
11. De Frang RD, Edwards JM, Moneta GL, Yeager RA, Taylor LM Jr, Porter JM: Repeat leg bypass after multiple prior bypass failures. J Vasc Surg 19:268-276, 1994
12. Edwards JE, Taylor LM Jr, Porter JM: Treatment of failed lower extremity bypass grafts with new autogenous vein bypass grafting. J Vasc Surg 11:136-145, 1990
13. McNamara TO, Fischer JR: Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase. Am J Roentgenol 144:769-775, 1995
14. Semba CP, Murphy TP, Bakal CW, Calis KA, Matalon TA: Thrombolytic therapy with use of alteplase (rt-PA) in peripheral arterial occlusive disease: review of the clinical literature. The Advisory Panel. J Vasc Interv Radiol 11(2 Pt 1):149-161, 2000
15. Ouriel K, Katzen B, Mewissen MW, et al: Initial experience with reteplase in the treatment of peripheral arterial and venous occlusion. J Vasc Interv Radiol 11:849-854, 2000
16. McNamara TO: Thombolysis as the initial treatment for acute lower limb ischemia, in Comerota AJ (ed): Thrombolytic Therapy for Peripheral Vascular Disease. Philadelphia, JB, Lippincott Company. 1995. pp 253-268
17. Faggioli GL, Peer RM, Pedrini L, et al: Failure of thrombolytic therapy to improve long-term vascular patency. J Vasc Surg 19:289-296, 1994
18. Korn P, Khilnani NM, Fellers JC, et al: Thrombolysis for native arterial occlusions of the lower extremities: clinical outcome and cost. J Vasc Surg 33:1148-1157, 2001
19. Sullivan KL, Gardiner GAJ, Kandarpa K, et al: Efficacy of thrombolysis in infrainguinal bypass grafts. Circulation 83:99-105, 1991 (suppl 2)
20. Milstone H: A factor in normal human blood which participates in streptococcal fibrinolysis. J Immunol 42:116, 1941
21. Cliffton EE, Grunnet M: Investigations of intravenous plasmin (fibrinolysin) in humans. Circulation 14:919, 1956
22. Onundarson PT, Haraldsson HM, Bergmann L, Francis CW, Marder VJ: Plasminogen depletion during streptokinase treatment or two-chain urokinase incubation correlates with decreased clot lysability ex vivo and in vitro. Thromb Haemostasis 70:998-1004, 1993
23. Tillen WS, Garner RL: The fibrinolytic activity of hemolytic streptococci. J Exp Med 58:485, 1933
24. Jostring H, Barth U, Naidu R: Changes of antistreptokinase titer following long-term streptokinase therapy, in Martin M, Schoop W, Hirsh J (eds): New Concepts of Streptokinase Dosimetry. Vienna, Hans Huber, 1978, pp 110
25. Macfarlane RG, Pinot JJ: Fibrinolytic activity of normal urine. Nature 159:779, 1947
26. Sobel GW, Mohler SR, Jones NW, Dowdy ABC, Guest MM: Urokinase: an activator of plasma fibrinolysin extracted from urine. Am J Physiol 171:768-769, 1952
27. Credo RB, Burke SE, Barker WM, et al: Recombinant urokinase (r-UK): biochemistry, pharmacology, and clinical experience, in Sasahara AA, Loscalzo J (eds): New Therapeutic Agents in Thrombosis and Thrombolysis. New York, Marcel Dekker, Inc., 1997, pp 513-537
28. Husain SS, Lipinski B, Gurewich V, inventors: Isolation of plasminogen activators useful as therapeutic and diagnostic agents (single-chair, high-fibrin affinity urokinase).4:381, 346, 1979
29. Hoylaerts M, Rijken DC, Lijnen HR, Collen D: Kinetics of the activation of plasminogen by human tissue plasminogen activator: role of fibrin. J Biol Chem 257:2912, 1982
30. Cannon CP, Gibson CM, McCabe CH, et al: TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIM1 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. Circulation 98:2805-2814, 1998
31. Semba CP, Weck S, Razavi MK, Tuomi L, Patapoff T: Tenecteplase: stability and bioactivity of thawed or diluted solutions used in peripheral thrombolysis. J Vasc Interv Radiol 14:475-479, 2003
32. Burkart DJ, Borsa JJ, Anthony JP, Thurlo SR: Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study. J Vasc Interv Radiol 14:729-734, 2003
33. The GUSTO Investigators: An international randomized trial comparing four thrombolytic therapies for acute myocardial infarction. N Engl J Med 329:673-682, 1993
34. Meierhenrich R, Carlsson J, Seifried E, et al: Effect of reteplase on hemostasis variables: analysis of fibrin specificity, relation to bleeding complications and coronary patency. Int J Cardiol 65:57-63, 1998
35. Valji K: Evolving strategies for thrombolytic therapy of peripheral vascular occlusion. J Vasc Interv Radiol 11:411-420, 2000
36. Ahmed NK, Tennant KD, Markland FS, Lacz JP: Biochemical characteristics of fibrolase, a fibrinolytic protease from snake venom. Haemostasis 20:147-154, 1990
37. Ahmed NK, Gaddis RR, Tennant KD, Lacz JP: Biological and thrombolytic properties of fibrolase - a new fibrinolytic protease from snake venom. Haemostasis 20:334-340, 1990
38. Markland FS: Fibrolase, an active thrombolytic enzyme in arterial and venous thrombosis model systems. Adv Exp Med Biol 391:427-438, 1996
39. Markland FS, Friedrichs GS, Pewitt SR, Lucchesi BR: Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis. Circulation 90:2448-2456, 1994
40. Weaver FA, Comerota AJ, Youngblood M, Froehlich J, Hosking JD, Papanicolaou G: Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity. J Vasc Surg 24:513-521, 1996
41. Comerota AJ, Weaver FA, Hosking JD, et al: Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts. Am J Surg 172:105-112, 1996
42. Ouriel K, Veith FJ, Sasahara AA: Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators. J Vasc Surg 23:64-73[see comments], 1996
43. Silva JA, Ramee SR, Collins TJ, et al: Rheolytic thrombectomy in the treatment of acute limb-threatening ischemia: immediate results and six-month follow-up of the multicenter AngioJet registry. Possis Peripheral AngioJet Study AngioJet Investigators, Cathet Cardiovasc Diagn 45:386-393, 1998
44. Kasirajan K, Gray B, Beavers FP, et al: Rheolytic thrombectomy in the management of acute and subacute limb-threatening ischemia. J Vasc Interv Radiol 12:413-421, 2001
45. Resolution 360 Therapeutic Wire. Data on file at OmniSonics. 2002